Boston Carriers (BSTN) S-1 4 Oct 13 2012 FY IPO registration Financial data

Document_and_Entity_Informatio

Document and Entity Information	12 Months Ended
	Dec. 31, 2012
Document And Entity Information
Entity Registrant Name	Inpatient Clinical Solutions Inc
Entity Central Index Key	1174672
Document Type	S-1
Document Period End Date	31-Dec-12
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	No
Entity Filer Category	Smaller Reporting Company
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2012

Balance_Sheets_Annual_Report

Balance Sheets (Annual Report) (Annual Report [Member], USD $)	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Current assets
Cash	$927,895	$13,699
Accounts receivable, net	137,471	1,186,554
Refundable income taxes	69,585	22,347
Deferred tax asset		12,600
Prepaid expenses and other current assets	421,197	67,301
Total current assets	1,556,148	1,302,501
Property and equipment, net	11,824	14,621
Other assets
Deposits	6,000	6,000
Other assets	144,222
TOTAL ASSETS	1,718,194	1,323,122
Current liabilities
Bank overdraft		20,475
Accounts payable and accrued liabilities	61,012	294,555
Accrued legal settlement	79,379	117,865
Loans payable - related parties	7,000	53,000
Debt to financial institutions		494,194
Total current liabilities	147,391	980,089
TOTAL LIABILITIES	147,391	980,089
Stockholders Equity
Preferred stock, $0.0001 par value, 250,000 and 750,000 shares authorized, issued and outstanding as of December 31, 2012 and 2011, respectively	25	75
Common stock, $0.0001 par value, 100,000,000 shares authorized, 48,612,365 and 43,612,365 shares issued and outstanding as of December 31, 2012 and 2011, respectively.	4,861	4,361
Additional paid-in capital	137,114	137,564
Retaining earnings	1,428,803	201,033
Total Stockholders Equity	1,570,803	343,033
Total Liabilities and Stockholders Equity	$1,718,194	$1,323,122

Balance_Sheets_Annual_Report_P

Balance Sheets (Annual Report) (Parenthetical) (Annual Report [Member], USD $)	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	250,000	750,000
Preferred Stock, Shares Outstanding	250,000	750,000
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares Issued	48,612,365	48,612,365
Common Stock, Shares Outstanding	43,612,365	43,612,365

Balance_Sheets_Unaudited

Balance Sheets (Unaudited) (Quarterly Report [Member], USD $)	Jun. 30, 2013	Dec. 31, 2012
Quarterly Report [Member]
CURRENT ASSETS
Cash	$452,116	$927,895
Accounts receivable, net		137,471
Refundable income taxes	69,585	69,585
Prepaid expenses and other current assets	483,242	421,197
Total current assets	1,004,943	1,556,148
Property and equipment, net	5,953	11,824
Other assets
Deposits	6,000	6,000
Other assets	184,961	144,222
TOTAL ASSETS	1,201,857	1,718,194
CURRENT LIABILITIES
Accounts payable and accrued liabilities	72,455	61,012
Accrued legal settlement	79,379	79,379
Loans payable - related parties	7,000	7,000
Total current liabilities	158,834	147,391
TOTAL LIABILITIES	158,834	147,391
Stockholders Equity
Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 250,000 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively	25	25
Common stock, $0.0001 par value, 100,000,000 shares authorized, 48,612,365 shares issued and outstanding as of June 30, 2013 and December 31, 2012, respectively.	4,861	4,861
Additional paid-in capital	137,114	137,114
Retaining earnings	901,023	1,428,803
Total Stockholders Equity	1,043,023	1,570,803
Total Liabilities and Stockholders Equity	$1,201,857	$1,718,194

Balance_Sheets_Parenthetical

Balance Sheets (Parenthetical) (Quarterly Report [Member], USD $)	Jun. 30, 2013	Dec. 31, 2012
Quarterly Report [Member]
Preferred Stock, Par Value	$0.00	$0.00
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	250,000	250,000
Preferred Stock, Shares Outstanding	250,000	250,000
Common Stock, Par Value	$0.00	$0.00
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares Issued	48,612,365	48,612,365
Common Stock, Shares Outstanding	48,612,365	48,612,365

Statements_of_Operations_Annua

Statements of Operations (Annual Report) (Annual Report [Member], USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Operating expenses from continuing operations:
General and administrative	$100,877	$60,953
Total operating expenses from continuing operations	100,877	60,953
Benefit from income taxes on continued operations	31,579
Loss from continuing operations	-69,298	-60,953
Discontinued operations:
Income (loss) from discontinued operations	4,338,724	-529,332
Provision (benefit) for income taxes	1,610,509	-12,600
Income (loss) on discontinued operations	2,728,215	-516,732
Net income (loss)	$2,658,917
Net income (loss) per share - basic
Loss from continuing operations	$0	$0
Income (loss) from discontinued operations	$0.05	($0.01)
Net income (loss) per share - basic	$0.05	($0.01)
Net income (loss) per share - diluted
Loss from continuing operations	$0	$0
Income (loss) from discontinued operations	$0.05	($0.01)
Net income (loss) per share - diluted	$0.05	($0.01)
Weighted average number of common shares outstanding - basic	46,597,338	43,612,365
Weighted average number of common shares outstanding - diluted	49,097,338	43,612,365

Statements_of_Operations_Unaud

Statements of Operations (Unaudited) (Quarterly Report [Member], USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Quarterly Report [Member]
Revenue	$2,162		$2,162
Cost of services			5,741
Gross Income (Loss)	2,162		-3,579
Operating expenses
General and administrative	111,787	49,579	196,170	81,762
Total operating expenses	111,787	49,579	196,170	81,762
Loss from continuing operations	-109,625	-49,579	-199,749	-81,762
Discontinued operations:
Income (loss) from discontinued operations	-147,541	-1,179,787	-328,031	-5,699,764
Provision (benefit) from income taxes		437,654		2,000,009
Income (loss) on discontinued operations	-147,541	-742,133	-328,031	-3,699,755
Net income (loss)	($257,166)	($791,712)	($527,780)	($3,617,993)
Net income (loss) per share - basic
Loss from continuing operations	$0	$0	$0	$0
Income (loss) from discontinued operations	$0	($0.02)	($0.01)	$0.08
Net income (loss) per share - basic	($0.01)	($0.02)	($0.01)	$0.08
Net income (loss) per share - diluted
Loss from continuing operations	$0	$0	$0	$0
Income (loss) from discontinued operations	$0	($0.02)	($0.01)	$0.08
Net income (loss) per share - diluted	($0.01)	($0.02)	($0.01)	$0.08
Weighted average number of common shares outstanding - basic	48,612,365	45,507,969	48,612,365	44,560,167
Weighted average number of common shares outstanding - diluted	48,612,365	45,507,969	48,612,365	47,060,167

Statements_of_Cash_Flows_Annua

Statements of Cash Flows (Annual Report) (Annual Report [Member], USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Net Income (Loss)	$2,658,917
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	2,797	5,997
Deferred income tax	12,600	9,747
Gain on sale of assets	-6,500,000
Changes in assets and liabilities:
Accounts receivable	1,049,083	347,310
Refundable income taxes	-47,238	-22,347
Prepaid expenses and other current assets	-53,896	-36,171
Other assets	-144,222
Accounts payable and accrued expenses	-233,544	77,030
Accrued legal settlement	-38,486	117,865
Net cash used in operating activities	-3,293,989	-78,254
Cash Flows From Investing Activities
Proceeds from sale of assets	6,200,000
Net cash provided by investing activities	6,200,000
Cash Flows From Financing Activities
Overdraft	-20,475	20,475
Proceeds (repayments) of loans payable - related parties	-46,000	53,000
Repayment of long term debt	-494,194	-49,607
Dividends paid	-1,431,146
Net cash (used in) provided by financing activities	-1,991,815	23,868
Net increase (decrease) in cash	914,196	-54,386
Cash - Beginning of year	13,699	68,085
Cash - End of year	927,895	13,699
Supplemental cash flow information:
Cash paid for interest	6,797	24,000
Cash paid during the year for taxes	$1,613,568
Supplemental of non-cash transactions:
Common stock issued upon conversion of preferred stock	500

Statements_of_Cash_Flows_Unaud

Statements of Cash Flows (Unaudited) (Quarterly Report [Member], USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Quarterly Report [Member]
Net Income (Loss)	($527,780)	($3,617,993)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation	5,871	1,399
Gain on sale of assets		-6,500,000
Changes in assets and liabilities:
Accounts receivable	137,471	230,193
Prepaid expenses and other current assets	-62,045	332,144
Other assets	-40,739	-205,336
Accounts payable and accrued liabilities	11,443	-241,060
Accrued legal settlement		-38,486
Net cash used in operating activities	-475,779	-2,803,153
Cash Flows From Investing Activities
Proceeds from sale of assets		6,200,000
Net cash provided by investing activities		6,200,000
Cash Flows From Financing Activities
Overdraft		-20,475
Repayment of long term debt		-494,194
Loans payable - related parties		-46,000
Dividends paid		-1,431,146
Net cash (used in) provided by financing activities		-1,991,815
Net (decrease) increase in cash	-475,779	1,405,032
Cash - Beginning of year	927,895	13,699
Cash - End of year	452,116	1,418,731
Supplemental cash flow information:
Cash paid for interest		6,797
Cash paid for income taxes		$1,613,568

Shareholders_Equity

Shareholders Equity (Annual Report [Member], USD $)	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings	Annual Report [Member]
	Annual Report [Member]	Annual Report [Member]	Annual Report [Member]	Annual Report [Member]	USD ($)
	USD ($)	USD ($)	USD ($)	USD ($)
Beginning Balance, Amount at Dec. 31, 2010	$75	$4,361	$137,564	$778,718	$920,718
Beginning Balance, Shares at Dec. 31, 2010	750,000	43,612,365
Net Income				-577,685
Ending Balance, Amount at Dec. 31, 2011	75	4,361	137,564	201,033	343,033
Ending Balance, Shares at Dec. 31, 2011	750,000	43,612,365
Dividends Paid					-1,431,147
Net Income					2,658,917
Ending Balance, Amount at Dec. 31, 2012	$25	$4,861	$137,114	$1,428,803	$1,570,803
Ending Balance, Shares at Dec. 31, 2012	250,000	48,612,365

NOTE_1_ORGANIZATION_AND_BUSINE

NOTE 1 - ORGANIZATION AND BUSINESS ACTIVITY (Annual Report) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 1 - ORGANIZATION AND BUSINESS ACTIVITY	NOTE 1 - ORGANIZATION AND BUSINESS ACTIVITY
	The Company was incorporated in Florida on July 31, 2001. On September 21, 2001, the Company was acquired by PlaNet.Com, Inc., a Nevada public, non-reporting corporation. Pla.Net.Com, Inc. was considered a shell at the time of acquisition and therefore the acquisition was treated as a reverse merger (the acquired company is treated as the acquiring company for accounting purposes). Pla.Net.Com, Inc. changed its name to Inpatient Clinical Solutions, Inc. immediately after the merger.
	Through March 2013, the Company provided health care services in South Florida. The Company provided inpatient physician care to various health care facilities and health plans in the South Florida area. Prior to February 2012, the Company provided Hospitalist services at acute care hospitals. Hospitalists focus on a patient’s care from the time of admission to discharge, working in close consultation with primary care physicians, other referring physicians and medical providers to coordinate the inpatient care delivery system and manage the entire inpatient episode of care.
	As more fully described in note 3, the Company sold the hospitalist business during February 2012. At that time, the Company changed its name from Inpatient Clinical Solutions, Inc. to Integrated Inpatient Solutions, Inc. In November 2011, the Company entered into an agreement with a hospital to provide intensivist services. Under the exclusive agreement, the Company provided critical care intensivist coverage for all medical and surgical intensive care unit patients at the hospital. The physicians include full-time employees, part-time and temporary physicians as well as contracted physician providers. The intensivist agreement was terminated in January 2013.
	The Company is developing an interior design business targeting budget minded individuals. The business operates under the trade name Integrated Interior Design. The Company expects to earn revenues from providing decorator services which are billed on hourly and per diem rates. The interior design business will initially operate in South Florida and will expand regionally and nationally. The business provides interior design, interior staging, accompanied shopping, paint color selection, architectural drawing and other design services.

NOTE_1_ORGANIZATION_AND_BUSINE1

NOTE 1 - ORGANIZATION AND BUSINESS ACTIVITY (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
NOTE 1 - ORGANIZATION AND BUSINESS ACTIVITY	NOTE 1 - ORGANIZATION AND BUSINESS ACTIVITY
	The Company was incorporated in Florida on July 31, 2001. On September 21, 2001 the Company was acquired by PlaNet.Com, Inc., a Nevada public, non-reporting corporation. Pla.Net.Com, Inc. was considered a shell at the time of acquisition and therefore the acquisition was treated as a reverse merger (the acquired company is treated as the acquiring company for accounting purposes). Pla.Net.Com, Inc. changed its name to Inpatient Clinical Solutions, Inc. immediately after the merger.
	Through March 2013, the Company provided health care services in South Florida. The Company provided inpatient physician care to various health care facilities and health plans in the South Florida area. Prior to February 2012, the Company provided Hospitalist services at acute care hospitals. Hospitalists focus on a patient’s care from the time of admission to discharge, working in close consultation with primary care physicians, other referring physicians and medical providers to coordinate the inpatient care delivery system and manage the entire inpatient episode of care.
	As more fully described in note 3, the Company sold the hospitalist business during February 2012. At that time, the Company changed its name from Inpatient Clinical Solutions, Inc. to Integrated Inpatient Solutions, Inc. In November 2011, the Company entered into an agreement with a hospital to provide intensivist services. Under the exclusive agreement, the Company provided critical care intensivist coverage for all medical and surgical intensive care unit patients at the hospital. The physicians include full-time employees, part-time and temporary physicians as well as contracted physician providers. The intensivist agreement was terminated in January 2013.
	The Company is developing an interior design business targeting budget minded individuals. The business operates under the trade name Integrated Interior Design. The Company expects to earn revenues from providing decorator services which are billed on hourly and per diem rates. The interior design business will initially operate in South Florida and will expand regionally and nationally. The business provides interior design, interior staging, accompanied shopping, paint color selection, architectural drawing and other design services.

NOTE_2_SUMMARY_OF_SIGNIFICANT_

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Annual Report) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Use of Estimates
	The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The areas involving the most significant use of estimates include the estimated realizable value of accounts receivable, contractual adjustment of gross billings, medical malpractice insurance receivable and payable for known claims and liabilities for claims incurred but not reported (IBNR) related to medical malpractice. These estimates are based on knowledge of current events and anticipated future events. The Company adjusts these estimates each period as more current information becomes available. The impact of any changes in estimates is included in the determination of earnings in the period in which the estimate is adjusted. Actual results may ultimately differ materially from those estimates.
	Cash
	The Company considers cash in banks and other highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition to be cash and cash equivalents. At December 31, 2012 and 2011, the Company had no cash equivalents. The Company maintains cash accounts in financial institutions that are guaranteed by the Federal Deposit Insurance Corporation (“FDIC”). FDIC insurance has temporarily increased from $100,000 to $250,000 per depositor through December 31, 2013. Deposits in excess of FDIC insurance totaled approximately $637,000 at December 31, 2012 and $0 at December 31, 2011.
	Accounts Receivable
	Accounts receivable represent amounts due from third-party payors, including government sponsored Medicare and Medicaid programs, insurance companies and patients for medical services provided. Accounts receivable are recorded and stated at the amount expected to be collected and have been adjusted to reflect the differences between charges and the estimated reimbursable amounts.
	Accounts receivable balances as of December 31 were as follows:
			2012			2011
	Accounts Receivable		1,074,528		$	3,163,267
	Less Contractual Allowances and Allowances for Doubtful Accounts		(937,057	)		(1,976,713	)
			137,471		$	1,186,554
	Property and Equipment
	Property and equipment are recorded at cost and depreciated on a straight-line basis over the estimated useful life of the asset. Expenditures for major renewals and betterments that extend the useful lives of properly and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.
	Impairment of Long-Lived Assets
	The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered.
	The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts.  Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.  The Company determined that there were no impairments of long-lived assets as of December 31, 2012 or December 31, 2011.
	Fair Value of Financial Instruments
	U.S. GAAP for fair value measurements establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three levels. The fair value hierarchy gives the highest priority to quoted market prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). Level 2 inputs are inputs, other than quoted prices included within Level 1, which are observable for the asset or liability, either directly or indirectly. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, deposits, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments. The Company’s debt to financial institutions approximate the fair value of such instrument based upon management’s best estimate of interest rates that would be available to the Company for similar financial arrangement.
	Revenue Recognition
	Hospitalist/Intensivist - Revenue consists primarily of net patient service revenues that are recorded based upon established billing rates less allowances for contractual adjustments. Revenues are recorded during the period the healthcare services are provided, based upon the estimated amounts due from the patients and third party payors, including federal and state agencies (under the Medicare and Medicaid programs), managed care health plans and commercial insurance companies. Estimates of contractual allowances under third-party payor arrangements are based upon the payment terms specified in the related contractual agreements. Third-party payor contractual payment terms are generally based upon predetermined rates per diagnosis, per diem rates, or discounted fee-for-service rates.
	The Company derives a significant portion of its revenues from third party insurers and accordingly receives discounts from standard charges. The Company must estimate the total amount of these discounts to prepare its financial statements. The various managed care contracts under which these discounts must be calculated are complex and are subject to interpretation and adjustment. These interpretations sometimes result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract renegotiations occur frequently, necessitating regular review and assessment of the estimation process by management. Changes in estimates related to the allowance for contractual discounts affect revenues reported in the Company’s statements of operations in the period of the change.
	The Medicare and Medicaid reimbursing entities (“Entities”) provide a substantial portion of the Company revenues. These Entities are subject to numerous laws and regulations of federal, state and local governments, including but not limited to matters such as licensure, accreditation, participation requirements, reimbursement formulas and fraud and abuse. Compliance with standards and other regulations can be subject to future government review and interpretation. Any future changes in federal and state reimbursement funding mechanisms could affect the Company.
	Interior Design - The Company follows ASC 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company will recognize revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when it has persuasive evidence of an arrangement that the services have been rendered to the customer, the sales rice is fixed or determinable, and collectability is reasonably assured.
	Income Taxes
	The Company follows Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Statements of Operations in the period that includes the enactment date.
	The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of Section 740-10-25.
	Earnings Per Share
	The Company computes earnings per share in accordance with the provisions of FASB ASC Topic 260, "Earnings Per Share," which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock.  Basic earnings per share are computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding during the period.  Diluted earnings per share are computed assuming the exercise of dilutive stock options under the treasury stock method and the related income tax effects.
	As of December 31, 2012 and 2011, we had 250,000 and 750,000 shares of Convertible Preferred Stock outstanding convertible into 2,500,000 and 7,500,000 common shares, respectively.
	The following tables set forth the computation of basic and diluted earnings per share as shown on the face of the accompanying Statements of Operations:
		Years Ended December 31,
		2012								2011
		Net Income			Shares			Per Share Amount		Net Loss			Shares		Per Share Amount
	Basic Earnings per Share:	$	2,658,917							$	(577,685	)
	Net income (loss)
	Amount allocated to participating securities		(210,000	)							—
	Net income available for basic common shares and basic earnings per share	$	2,448,917			46,597,338		$	0.05	$	(577,685	)		43,612,365	$	(0.01	)
	Diluted Earnings per Share:
	Net income (loss)	$	2,658,617							$	(577,685	)
	Amount allocated to participating securities		(210,000	)
	Adjustment for dilutive potential common shares					2,500,000					—			—
	Net income available for diluted common shares and diluted earnings per share	$	2,448,917			49,097,338		$	0.05	$	(577,685	)		43,612,365	$	(0.01	)
	Recent Accounting Pronouncements
	In August 2010, the Financial Accounting Standard Board (FASB) issued revised GAAP on the presentation of insurance claims and related insurance recoveries. The revised GAAP requires a healthcare entity to present medical malpractice claims and similar liabilities without consideration of insurance recoveries. Related insurance recoveries are to be presented as a receivable net of a valuation allowance for uncollectible amounts. The accompanying financial statements present reserves for known malpractice claims. As of December 31, 2012 and 2011, the company had no receivables for related insurance recoveries. Had any such receivables existed, they would be presented on an undiscounted basis based upon loss projections.

NOTE_2_SUMMARY_OF_SIGNIFICANT_1

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	BASIS OF PRESENTATION
	The unaudited interim financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
	The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the six months ended June 30, 2013 are not necessarily indicative of the results to be expected for the year ending December 31, 2013.
	The information included in these interim unaudited condensed financial statements should be read in conjunction with the Company’s Registration Statement on Form S-1 for the year ended December 31, 2012.
	Use of Estimates
	The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The areas involving the most significant use of estimates include the estimated realizable value of accounts receivable, contractual adjustment of gross billings, medical malpractice insurance receivable and payables for known claims and liabilities for claims incurred but not reported (IBNR) related to medical malpractice. These estimates are based on knowledge of current events and anticipated future events. The Company adjusts these estimates each period as more current information becomes available. The impact of any changes in estimates is included in the determination of earnings in the period in which the estimate is adjusted. Actual results may ultimately differ materially from those estimates.
	Integrated Inpatient Solutions, Inc.
	Condensed Financial Statements
	30-Jun-13
	(Unaudited)
	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
	Cash
	The Company considers cash in banks and other highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition to be cash and cash equivalents. At June 30, 2013 and December 31, 2012, the Company had no cash equivalents. The Company maintains cash accounts in financial institutions that are guaranteed by the Federal Deposit Insurance Corporation (“FDIC”). FDIC insurance has increased from $100,000 to $250,000 per depositor as of December 31, 2012. Deposits in excess of FDIC insurance totaled approximately $159,000 and $637,000 at June 30, 2013 and December 31, 2012, respectively.
	Accounts Receivable
	Accounts receivable represent amounts due from third-party payors, including government sponsored Medicare and Medicaid programs, insurance companies and patients for medical services provided. Accounts receivable are recorded and stated at the amount expected to be collected and have been adjusted to reflect the differences between charges and the estimated reimbursable amounts.
	Accounts receivable balances as of June 30, 2013 and December 31, 2012 were as follows:
			2013			2012
	Accounts Receivable	$	—		$	1,074,528
	Less Contractual Allowances and Allowances for Doubtful Accounts		—			(937,057	)
		$	—		$	137,471
	Property and Equipment
	Property and equipment are recorded at cost and depreciated on a straight-line basis over the estimated useful life of the asset. Expenditures for major renewals and betterments that extend the useful lives of properly and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.
	Impairment of Long-Lived Assets
	The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered.
	The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives, against their respective carrying amounts.  Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.  The Company determined that there were no impairments of long-lived assets as of June 30, 2013 and December 31, 2012.
	Integrated Inpatient Solutions, Inc.
	Condensed Financial Statements
	30-Jun-13
	(Unaudited)
	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
	Fair Value of Financial Instruments
	U.S. GAAP for fair value measurements establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three levels. The fair value hierarchy gives the highest priority to quoted market prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). Level 2 inputs are inputs, other than quoted prices included within Level 1, which are observable for the asset or liability, either directly or indirectly. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, deposits, accounts payable and accrued liabilities, approximate their fair values because of the short maturity of these instruments.
	Revenue Recognition
	Hospitalist/Intensivist - Revenue consists primarily of net patient service revenues that are recorded based upon established billing rates less allowances for contractual adjustments. Revenues are recorded during the period the healthcare services are provided, based upon the estimated amounts due from the patients and third party payors, including federal and state agencies (under the Medicare and Medicaid programs), managed care health plans and commercial insurance companies. Estimates of contractual allowances under third-party payor arrangements are based upon the payment terms specified in the related contractual agreements. Third-party payor contractual payment terms are generally based upon predetermined rates per diagnosis, per diem rates, or discounted fee-for-service rates.
	The Company derives a significant portions of its revenues from third party insurers and accordingly receives discounts from standard charges. The Company must estimate the total amount of these discounts to prepare its financial statements. The various managed care contracts under which these discounts must be calculated are complex and are subject to interpretation and adjustment. These interpretations sometimes result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract renegotiations occur frequently, necessitating regular review and assessment of the estimation process by management. Changes in estimates related to the allowance for contractual discounts affect revenues reported in the Company’s statement of operations in the period of the change.
	The Medicare and Medicaid reimbursing entities (“Entities”) provide a substantial portion of the Company revenues. These Entities are subject to numerous laws and regulations of federal, state and local governments, including but not limited to matters such as licensure, accreditation, participation requirements, reimbursement formulas and fraud and abuse. Compliance with standards and other regulations can be subject to future government review and interpretation. Any future changes in federal and state reimbursement funding mechanisms could affect the Company.
	Interior Design - The Company follows ASC 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company will recognize revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when it has persuasive evidence of an arrangement that the services have been rendered to the customer, the sales price is fixed or determinable, and collectability is reasonably assured.
	Integrated Inpatient Solutions, Inc.
	Condensed Financial Statements
	30-Jun-13
	(Unaudited)
	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
	Income Taxes
	The Company follows Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Statements of Operations in the period that includes the enactment date.
	The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of Section 740-10-25.
	Earnings Per Share
	The Company computes earnings per share in accordance with the provisions of FASB ASC Topic 260, "Earnings Per Share," which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock.  Basic earnings per share are computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding during the period.  Diluted earnings per share are computed assuming the exercise of dilutive stock options under the treasury stock method and the related income tax effects.
	As of June 30, 2013 and 2012, we had 250,000 shares of Convertible Preferred Stock outstanding convertible into 2,500,000 common shares.
	The following tables set forth the computation of basic and diluted earnings per share as shown on the face of the accompanying Statements of Operations:
		For the Six Months Ended June 30,
		2013									2012
		Net Loss			Shares			Per Share Amount			Net Income			Shares		Per Share Amount
	Basic Earnings per Share:	$	(527,780	)							$	3,617,993
	Net income (loss)
	Amount allocated to participating securities		—									—
	Net income (loss) available for basic common shares and basic earnings per share	$	(527,780	)		48,612,365		$	(0.01	)	$	3,617,993			44,560,167	$	0.08
	Diluted Earnings per Share:
	Net income (loss)	$	(527,780	)							$	3,617,993
	Amount allocated to participating securities		—
	Adjustment for dilutive potential common shares		—			—						—			2,500,000
	Net income (loss) available for diluted common shares and diluted earnings per share	$	(527,780	)		48,612,365		$	(0.01	)	$	3,617,993			47,060,167	$	0.08
	Integrated Inpatient Solutions, Inc.
Condensed Financial Statements
30-Jun-13
(Unaudited)
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
	For the Three Months Ended June 30,
	2013									2012
	Net Loss			Shares			Per Share Amount			Net Loss			Shares		Per Share Amount
Basic Earnings per Share:	$	(257,166	)							$	(791,712	)
Net income (loss)
Amount allocated to participating securities		—									—
Net income (loss) available for basic common shares and basic earnings per share	$	(257,166	)		48,612,365		$	(0.01	)	$	(791,712	)		45,507,969	$	(0.02	)
Diluted Earnings per Share:
Net income (loss)	$	(257,166	)							$	(791,712	)
Amount allocated to participating securities
Adjustment for dilutive potential common shares		—			—						—			—
Net income (loss) available for diluted common shares and diluted earnings per share	$	(257,166	)		48,612,365		$	(0.01	)	$	(791,712	)		45,507,969	$	(0.02	)
Recent Accounting Pronouncements
There have been no accounting pronouncements or changes in accounting pronouncements during the six months ended June 30, 2013 that are expected to have a material impact on the Company’s financial position, results of operations or cash flows.  Accounting pronouncements that became effective during the six months ended June 30, 2013 did not have a material impact on disclosures or on the Company’s financial position, results of operations or cash flows.

NOTE_3_ASSET_SALE_Annual_Repor

NOTE 3 - ASSET SALE (Annual Report) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 3 - ASSET SALE	NOTE 3 - ASSET SALE
	On March 19, 2012, the Company executed an Asset Purchase Agreement (“APA”)_ with an unrelated third party to sell the facility agreements, provider agreements, payor contracts and other intangible assets related to the hospitalist business for a total purchase price of $6,500,000. The carrying value of the purchased assets was $0 resulting in a total gain on the sale of $6,500,000. The APA did not include rights to any cash, accounts receivable, prepaid expenses, deposits, property or equipment. No obligations or liabilities existing prior to the closing of the APA were assumed by the purchaser.
	Pursuant to the APA, $300,000 was placed in escrow for the purposes of indemnifying the sellers for a period of eighteen months. After eighteen months, the funds are available to the Company to use for operations.
	Under the APA, the Company and its officers are restricted from conducting hospitalist services for a period of 36 months from the closing date within a 50 mile radius of any facility from which it had previously conducted such services.

NOTE_3_ASSET_SALE

NOTE 3 - ASSET SALE (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
NOTE 3 - ASSET SALE	NOTE 3 - ASSET SALE
	On March 19, 2012, the Company executed an Asset Purchase Agreement (“APA”)_ with an unrelated third party to sell the facility agreements, provider agreements, payor contracts and other intangible assets related to the hospitalist business for a total purchase price of $6,500,000. The carrying value of the purchased assets was $0 resulting in a total gain on the sale of $6,500,000. The APA did not include rights to any cash, accounts receivable, prepaid expenses, deposits, property or equipment. No obligations or liabilities existing prior to the closing of the APA were assumed by the purchaser.
	Pursuant to the APA, $300,000 was placed in escrow for the purposes of indemnifying the sellers for a period of eighteen months. After eighteen months, the funds are available to the Company to use for operations.
	Under the APA, the Company and its officers are restricted from conducting hospitalist services for a period of 36 months from the closing date within a 50 mile radius of any facility from which it had previously conducted such services.

NOTE_4_PREPAID_EXPENSES_AND_OT

NOTE 4 - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Annual Report) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 4 - PREPAID EXPENSES AND OTHER CURRENT ASSETS	NOTE 4 - PREPAID EXPENSES AND OTHER CURRENT ASSETS
	Prepaid expenses and other current assets consist of the following at December 31, 2012 and 2011:
			2012		2011
	Escrow deposit held for indemnification	$	300,000	$	—
	Prepaid insurance-medical professional liability		121,197		26,741
	Other current assets		—		40,560
		$	421,197	$	67,301

NOTE_4_PREPAID_EXPENSES_AND_OT1

NOTE 4 - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
NOTE 4 - PREPAID EXPENSES AND OTHER CURRENT ASSETS	NOTE 4 - PREPAID EXPENSES AND OTHER CURRENT ASSETS
	Prepaid expenses and other current assets consist of the following at June 30, 2013 and December 31, 2012:
			2013		2012
	Escrow Deposit held for indemnification	$	300,000	$	300,000
	Prepaid insurance - medical professional liability		183,242		121,197
		$	483,242	$	421,197

NOTE_5_PROPERTY_AND_EQUIPMENT_

NOTE 5 - PROPERTY AND EQUIPMENT (Annual Report) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 5 - PROPERTY AND EQUIPMENT	NOTE 5 - PROPERTY AND EQUIPMENT
	The Company’s property and equipment consisted of the following at December 31, 2012 and 2011:
		2012			2011			Estimated Useful Life
	Computer and Office Equipment	$	33,868		$	33,868		5 -7 years
	Furniture and Fixtures		18,530			18,530		7 years
			52,398			52,398
	Less: Accumulated Depreciation		(40,574	)		(37,777	)
		$	11,824		$	14,621
	Depreciation expense for the years ended December 31, 2012 and 2011 was $2,797 and $5,997 respectively.

NOTE_5_PROPERTY_AND_EQUIPMENT

NOTE 5 - PROPERTY AND EQUIPMENT (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
NOTE 5 - PROPERTY AND EQUIPMENT	NOTE 5 - PROPERTY AND EQUIPMENT
	The Company’s property and equipment consisted of the following at December 31, 2012 and 2011:
		2012			2011			Estimated Useful Life
	Computer and Office Equipment	$	33,868		$	33,868		5 -7 years
	Furniture and Fixtures		18,530			18,530		7 years
			52,398			52,398
	Less: Accumulated Depreciation		(46,445	)		(40,574	)
		$	5,953		$	11,824
	Depreciation expense for the years ended December 31, 2012 and 2011 was $5,871 and $1,399 respectively.

NOTE_6_DEBT

NOTE 6 - DEBT (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 6 - DEBT	NOTE 6 - DEBT
	As of December 31, 2012 and 2011, debt obligations consisted of the following:
			2012		2011
	Note payable to Citibank payable $993 monthly. Interest accrues at a variable rate based upon a rate of prime plus 1%. The loan is secured by all property and assets of the Company and is personally guaranteed by certain members of management.	$	—	$	8,667
	Citibank, line of credit, payable over 60 months accruing interest at 4.25% per year. The original principal balance was $500,000. The loan is payable November, 25, 2012.		—		485,527
	Less current portion		—		(494,194	)
		$	—	$	—
	Long-term debt
	Interest expense was $6,797 and $23,889 for the years ended December 31, 2012 and 2011, respectively. During March 2012, the Company paid off the debt with Citibank for a total amount of $494,194.

NOTE_6_OTHER_ASSETS

NOTE 6 - OTHER ASSETS (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
NOTE 6 - OTHER ASSETS	NOTE 6 - OTHER ASSETS
	Other assets arise from prepayments on two medical malpractice insurance policies with coverage that indemnifies the Company on the claims-made basis. The policy periods end in February 2016 and March 2015, respectively. The Company recorded $183,242 in current assets and $184,961 in other assets.

NOTE_7_RELATED_PARTY_TRANSACTI

NOTE 7 - RELATED PARTY TRANSACTIONS (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 7 - RELATED PARTY TRANSACTIONS	NOTE 7 - RELATED PARTY TRANSACTIONS
	During 2012, the Company received advance of $7,000 from one officer.   This advance was unsecured, non-interest bearing and due on demand.
	During 2011, the Company received advances of $53,000 from two officers.   These advances were unsecured, non-interest bearing and due on demand. During March of 2012, the Company repaid the advances due to the officers.
	Included in accounts payable and accrued liabilities are accrued payroll amounts due to two officers of approximately $7,000 and $138,000 at December 31, 2012 and 2011, respectively.

NOTE_7_INCOME_TAXES

NOTE 7 - INCOME TAXES (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
NOTE 7 - INCOME TAXES	NOTE 7 - INCOME TAXES
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s net current and deferred income tax provision are as follows:
					Six Months Ended June 30, 2013								Six Months Ended June 30, 2012
					Total				Continuing Operations		Discontinued Operations		Total		Continuing Operations		Discontinued Operations
		Current:				—				—		—		2,000,009		—		2,000,009
		Total				—				—		—		2,000,009		—		2,000,009
	The following is a reconciliation of the effective income tax rate to the Federal statutory rate:
			2013				2012
	Statutory rate			34	%			30	%
	State income taxes, net of Federal tax benefit			5.5				5.5
				39.5				35.5
	Less: Valuation Allowance			(39.50	)			—
				0	%			35.5	%
	The accompanying unaudited condensed financial statements include refundable income taxes of $69,585 at June 30, 2013 and December 31, 2012. This amount represents the excess of federal and state income tax deposits over the expected tax liability.

NOTE_8_INCOME_TAXES

NOTE 8 - INCOME TAXES (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 8 - INCOME TAXES	NOTE 8 - INCOME TAXES
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s net current and deferred income tax provision are as follows:
					Fiscal year ended December 31, 2012									Fiscal year ended December 31, 2011
					Total				Continuing Operations			Discontinued Operations		Total		Continuing Operations		Discontinued Operations
		Current:			$	1,610,509			$	(31,579	)	$	1,414,181	$	—	$		$
		Deferred:			$	—			$			$		$	12,600	$		$	12,600
		Total			$	1,610,509			$	(31,579	)	$	1,414,181	$	12,600	$	—	$	12,600
	The tax effects of temporary differences which give rise to deferred tax assets at December 31, 2012 and 2011, are summarized as follows:
			2012				2011
	Deferred tax assets:
	Net operating loss		$	—			$	12,600
	Net deferred tax asset		$	—			$	12,600
	The following is a reconciliation of the effective income tax rate to the Federal statutory rate:
			2012				2011
	Statutory rate			34	%			34	%
	State income taxes, net of Federal tax benefit			5.5				5.5
	Permanent differences			—				(35.30	)
	Valuation allowance-deferred tax asset from NOL			—				(2.10	)
	Effective rate			39.5	%			(2.10	)%
	At December 31, 2012 and 2011, the Company had a net operating loss carry forwards for both federal and state purposes of approximately $0 and $32,000, respectively, which may be offset against future taxable income through 2031.
	The Company has determined that a valuation for the income tax provision was not required at December 31, 2011. A valuation allowance is required if, based on the weight of evidence, it is more likely than not that some or the entire portion of the deferred tax asset will not be realized. After consideration of all the evidence, both positive and negative, management has determined that a valuation allowance is not necessary to reduce the deferred tax asset.
	The accompanying financial statements include refundable income taxes of $69,585 and $22,347 at December 31, 2012 and 2011. These amounts represent the excess of federal and state income tax deposits over the expected tax liability.

NOTE_8_STOCKHOLDERS_EQUITY

NOTE 8 - STOCKHOLDERS' EQUITY (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
NOTE 8 - STOCKHOLDERS EQUITY	NOTE 8 - STOCKHOLDERS' EQUITY
	Preferred Stock
	The Company has 10,000,000 authorized shares of non-redeemable, convertible preferred stock with a par value of $.0001. Each share of preferred stock is convertible to 10 shares of commons stock. In May 2012, 500,000 of the 750,000 shares of preferred stock outstanding were converted into 5 million shares of common stock.
	Common Stock
	On February 14, 2012, the Company's stockholders approved an amendment to the Company’s Articles of Incorporation to increase the authorized number of shares of common stock, $.0001 par value, from 50,000,000 shares to 100,000,000 shares.

NOTE_9_STOCKHOLDERS_EQUITY

NOTE 9 - STOCKHOLDERS' EQUITY (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 9 - STOCKHOLDERS EQUITY	NOTE 9 - STOCKHOLDERS' EQUITY
	Preferred Stock
	The Company has 10,000,000 authorized shares of non-redeemable, convertible preferred stock with a par value of $.0001. Each share of preferred stock is convertible to 10 shares of commons stock. In May 2012, 500,000 of the 750,000 shares of preferred stock outstanding were converted into 5 million shares of common stock.
	Common Stock
	On February 14, 2012, the Company's stockholders approved an amendment to the Company’s Articles of Incorporation to increase the authorized number of shares of common stock, $.0001 par value, from 50,000,000 shares to 100,000,000 shares.
	Dividends
	During March and April of 2012, the Company paid dividends for $1,431,146.

NOTE_9_COMMITMENTS_AND_CONTING

NOTE 9 - COMMITMENTS AND CONTINGENCIES (Quarterly Report [Member])	12 Months Ended
	Dec. 31, 2012
Quarterly Report [Member]
NOTE 9 - COMMITMENTS AND CONTINGENCIES	NOTE 9 - COMMITMENT AND CONTINGENCIES
	Commitment
	In July 2007, the Company entered into a one year office lease agreement at $3,000 per month. The lease agreement expired and has been terminated. In April 2013, the Company entered into a new one year office lease agreement at $450 per month, the lease expires in May 2014. Total rent expense for the periods ended June 30, 2013 and June 30, 2012 was $7,866 and $12,941, respectively.
	Contingencies
	In the ordinary course of our business, the Company becomes involved in lawsuits and legal proceedings involving claims of medical malpractice related to medical services provided by our affiliated physicians. The Company is currently involved in one such matter where the claim could exceed insurance coverage. This matter is in the early stages of discovery and an estimate of loss, if any, cannot currently be made.
	The Company is currently not aware of any other such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse affect on its business, financial condition or operating results except for the item described below. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business.
	In November 2011, the Company became involved in a legal settlement relating to a malpractice claim for $100,000. As a result of the settlement agreement, the Company agreed to pay a total amount of $100,000. As of June 30, 2013 and December 31, 2012, the remaining balance is approximately $79,000 which is due in equal yearly installments of $20,000 over the next four years.
	Regulatory Matters
	Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. Compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from the Medicare and Medicaid programs. We believe that we are in compliance with all applicable laws and regulations. We are not aware of any specific investigations involving allegations of potential wrongdoing.

NOTE_10_COMMITMENTS_AND_CONTIN

NOTE 10 - COMMITMENTS AND CONTINGENCIES (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 10 - COMMITMENTS AND CONTINGENCIES	NOTE 10 - COMMITMENTS AND CONTINGENCIES
	Commitments
	In July 2007, the Company entered into a one year office lease agreement at $3,000 per month. The lease agreement expired and is currently a month to month agreement that can be terminated at any time. Total rent expense for the years ended December 31, 2012 and 2011 was $23,150 and $34,301, respectively.
	Contingencies
	In the ordinary course of our business, the Company becomes involved in lawsuits and legal proceedings involving claims of medical malpractice related to medical services provided by our affiliated physicians. The Company is currently involved in one such matter where the claim could exceed insurance coverage. This matter is in the early stages of discovery and an estimate of loss, if any, cannot currently be made.
	The Company is currently not aware of any other such legal proceedings or claims that they believe will have, individually or in the aggregate, a material adverse affect on its business, financial condition or operating results except for the item described below. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm its business.
	In October 2011, the Company became involved in a legal settlement relating to an AHCA settlement for approximately $30,000. As a result of the settlement agreement, the Company agreed to pay a total amount of approximately $30,000, which was paid in full as of December 31, 2012.
	In November 2011, the Company became involved in a legal settlement relating to a malpractice claim for $100,000. As a result of the settlement agreement, the Company agreed to pay a total amount of $100,000. As of December 31, 2012, the Company still has a remaining balance of approximately $79,000 which is due in equal yearly installments of $20,000 over the next four years.
	Regulatory Matters
	Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. Compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from the Medicare and Medicaid programs. We believe that we are in compliance with all applicable laws and regulations. We are not aware of any specific investigations involving allegations of potential wrongdoing.

NOTE_10_CONCENTRATIONS

NOTE 10 - CONCENTRATIONS (Quarterly Report [Member])	12 Months Ended
	Dec. 31, 2012
Quarterly Report [Member]
NOTE 10 - CONCENTRATIONS	NOTE 10 - CONCENTRATIONS
	Revenue
	The Company has one affiliated medical provider, who is a director of the Company with revenues that represented approximately 4% and 2% of net revenues as of June 30, 2013 and June 30, 2012, respectively.
	The Company’s top 3 unaffiliated medical providers represented approximately 96% of revenues for the six month period ended June 30, 2013. The Company’s top 3 unaffiliated providers represented approximately 35% of revenues for the six month period ended June 30, 2012.  The Company enjoyed good relations with these providers. However, the loss of any of these providers, if they had not been replaced, could have had an adverse impact on the Company’s operations.

NOTE_11_CONCENTRATIONS

NOTE 11 - CONCENTRATIONS (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 11 - CONCENTRATIONS	NOTE 11 - CONCENTRATIONS
	Revenue
	The Company has one affiliated provider, who is a director of the Company with revenues that represented approximately 1% and 6% of net revenues as of December 31, 2012 and 2011, respectively.
	The Company’s top five unaffiliated providers represented approximately 94% of revenues for the year ended December 31, 2012. The Company’s top five unaffiliated providers represented approximately 33%, of revenues for the year ended December 31, 2011.  The Company enjoys good relations with these providers. However, the loss of any of these providers, if not replaced, could have an adverse impact on the Company’s operations.

NOTE_11_Discontinued_Operation

NOTE 11 - Discontinued Operations (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
NOTE 11 - Discontinued Operations	NOTE 11 - Discontinued Operations
	In March 2013, management decided to exit the health care provider business and change the Company's strategy in order to focus on its interior design business. Accordingly, the financial statements have been presented in accordance with ASC 205-20, Discontinued Operations.
	The following table illustrates the reporting of the discontinued operations included in the Statements of Operations for the periods ended June 30, 2013 and 2012:
		Six Months Ended June 30,
		2013			2012
	Patient Service Revenue (net of contractual allowances and discounts)	$	109,463		$	4,294,812
	Operating expenses:
	Cost of services-physicians		225,964			2,054,757
	General and administrative		211,530			3,033,497
	Total operating expenses		437,494			5,088,254
	Other income (expenses)
	Interest expense, net		—			(6,794	)
	Gain on sale of assets		—			6,500,000
	Total other income (expenses)		—			6,493,206
	Income (loss) on discontinued operations	$	(328,031	)	$	5,699,764

NOTE_12_DISCONTINUED_OPERATION

NOTE 12 - DISCONTINUED OPERATIONS (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 12 - Discontinued Operations	NOTE 12 - Discontinued Operations
	In March 2013, management decided to exit the health care provider business and change the Company's strategy in order to focus on its interior design business. Accordingly, the financial statements have been presented in accordance with ASC 205-20, Discontinued Operations.
	The following table illustrates the reporting of the discontinued operations included in the Statements of Operations for the years ended December 31, 2012 and 2011:
		2012			2011
	Patient Service Revenue (net of contractual allowances and discounts)	$	2,785,498		$	6,777,591
	Operating expenses:
	Cost of services-physicians		3,234,533			5,731,549
	General and administrative		1,705,449			1,451,496
	Professional liability settlement		—			100,000
	Total operating expenses		4,939,982			7,283,045
	Other income (expense)
	Interest expense, net		(6,792	)		(23,878	)
	Gain on sale of assets		6,500,000			—
	Total other income (expenses)		6,493,208			(23,878	)
	Income (loss) from discontinued operation	$	4,338,724		$	(529,332	)
	The Company expects to receive funds from the collection of accounts receivable related to discontinued operations through July 2013.

NOTE_12_SUBSEQUENT_EVENT

NOTE 12 - SUBSEQUENT EVENT (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
Disclosure - NOTE 12 - SUBSEQUENT EVENT (USD $)	NOTE 12 – SUBSEQUENT EVENT
	In preparing these interim condensed unaudited financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through September 24, 2013, the date the financial statements were issued.

NOTE_13_SUBSEQUENT_EVENTS

NOTE 13 - SUBSEQUENT EVENTS (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
NOTE 13 - SUBSEQUENT EVENTS	NOTE 13 - SUBSEQUENT EVENTS
	As disclosed in Note 1, through March 2013, the Company provided health care services in South Florida.
	As disclosed in Note 12, in March 2013, management decided to exit the health care provider business and change the Company's strategy in order to focus on its interior design business.
	In preparing these financial statements, the Company has evaluated events and transactions for potential recognition or disclosure through September 23, 2013, the date the financial statements were issued.

NOTE_2_SUMMARY_OF_SIGNIFICANT_2

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) (Annual Report) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
Use of Estimates
	Use of Estimates
	The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The areas involving the most significant use of estimates include the estimated realizable value of accounts receivable, contractual adjustment of gross billings, medical malpractice insurance receivable and payable for known claims and liabilities for claims incurred but not reported (IBNR) related to medical malpractice. These estimates are based on knowledge of current events and anticipated future events. The Company adjusts these estimates each period as more current information becomes available. The impact of any changes in estimates is included in the determination of earnings in the period in which the estimate is adjusted. Actual results may ultimately differ materially from those estimates.
Cash	Cash
	The Company considers cash in banks and other highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition to be cash and cash equivalents. At December 31, 2012 and 2011, the Company had no cash equivalents. The Company maintains cash accounts in financial institutions that are guaranteed by the Federal Deposit Insurance Corporation (“FDIC”). FDIC insurance has temporarily increased from $100,000 to $250,000 per depositor through December 31, 2013. Deposits in excess of FDIC insurance totaled approximately $637,000 at December 31, 2012 and $0 at December 31, 2011.
Accounts Receivable	Accounts Receivable
	Accounts receivable represent amounts due from third-party payors, including government sponsored Medicare and Medicaid programs, insurance companies and patients for medical services provided. Accounts receivable are recorded and stated at the amount expected to be collected and have been adjusted to reflect the differences between charges and the estimated reimbursable amounts.
	Accounts receivable balances as of December 31 were as follows:
			2012			2011
	Accounts Receivable		1,074,528		$	3,163,267
	Less Contractual Allowances and Allowances for Doubtful Accounts		(937,057	)		(1,976,713	)
			137,471		$	1,186,554
Property and Equipment	Property and Equipment
	Property and equipment are recorded at cost and depreciated on a straight-line basis over the estimated useful life of the asset. Expenditures for major renewals and betterments that extend the useful lives of properly and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets
	The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered.
	The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts.  Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.  The Company determined that there were no impairments of long-lived assets as of December 31, 2012 or December 31, 2011.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	U.S. GAAP for fair value measurements establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three levels. The fair value hierarchy gives the highest priority to quoted market prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). Level 2 inputs are inputs, other than quoted prices included within Level 1, which are observable for the asset or liability, either directly or indirectly. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, deposits, accounts payable and accrued expenses, approximate their fair values because of the short maturity of these instruments. The Company’s debt to financial institutions approximate the fair value of such instrument based upon management’s best estimate of interest rates that would be available to the Company for similar financial arrangement.
Revenue Recognition	Revenue Recognition
	Hospitalist/Intensivist - Revenue consists primarily of net patient service revenues that are recorded based upon established billing rates less allowances for contractual adjustments. Revenues are recorded during the period the healthcare services are provided, based upon the estimated amounts due from the patients and third party payors, including federal and state agencies (under the Medicare and Medicaid programs), managed care health plans and commercial insurance companies. Estimates of contractual allowances under third-party payor arrangements are based upon the payment terms specified in the related contractual agreements. Third-party payor contractual payment terms are generally based upon predetermined rates per diagnosis, per diem rates, or discounted fee-for-service rates.
	The Company derives a significant portion of its revenues from third party insurers and accordingly receives discounts from standard charges. The Company must estimate the total amount of these discounts to prepare its financial statements. The various managed care contracts under which these discounts must be calculated are complex and are subject to interpretation and adjustment. These interpretations sometimes result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract renegotiations occur frequently, necessitating regular review and assessment of the estimation process by management. Changes in estimates related to the allowance for contractual discounts affect revenues reported in the Company’s statements of operations in the period of the change.
	The Medicare and Medicaid reimbursing entities (“Entities”) provide a substantial portion of the Company revenues. These Entities are subject to numerous laws and regulations of federal, state and local governments, including but not limited to matters such as licensure, accreditation, participation requirements, reimbursement formulas and fraud and abuse. Compliance with standards and other regulations can be subject to future government review and interpretation. Any future changes in federal and state reimbursement funding mechanisms could affect the Company.
	Interior Design - The Company follows ASC 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company will recognize revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when it has persuasive evidence of an arrangement that the services have been rendered to the customer, the sales rice is fixed or determinable, and collectability is reasonably assured.
Income Taxes	Income Taxes
	The Company follows Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Statements of Operations in the period that includes the enactment date.
	The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of Section 740-10-25.
Earnings Per Share	Earnings Per Share
	The Company computes earnings per share in accordance with the provisions of FASB ASC Topic 260, "Earnings Per Share," which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock.  Basic earnings per share are computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding during the period.  Diluted earnings per share are computed assuming the exercise of dilutive stock options under the treasury stock method and the related income tax effects.
	As of December 31, 2012 and 2011, we had 250,000 and 750,000 shares of Convertible Preferred Stock outstanding convertible into 2,500,000 and 7,500,000 common shares, respectively.
	The following tables set forth the computation of basic and diluted earnings per share as shown on the face of the accompanying Statements of Operations:
		Years Ended December 31,
		2012								2011
		Net Income			Shares			Per Share Amount		Net Loss			Shares		Per Share Amount
	Basic Earnings per Share:	$	2,658,917							$	(577,685	)
	Net income (loss)
	Amount allocated to participating securities		(210,000	)							—
	Net income available for basic common shares and basic earnings per share	$	2,448,917			46,597,338		$	0.05	$	(577,685	)		43,612,365	$	(0.01	)
	Diluted Earnings per Share:
	Net income (loss)	$	2,658,617							$	(577,685	)
	Amount allocated to participating securities		(210,000	)
	Adjustment for dilutive potential common shares					2,500,000					—			—
	Net income available for diluted common shares and diluted earnings per share	$	2,448,917			49,097,338		$	0.05	$	(577,685	)		43,612,365	$	(0.01	)
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	In August 2010, the Financial Accounting Standard Board (FASB) issued revised GAAP on the presentation of insurance claims and related insurance recoveries. The revised GAAP requires a healthcare entity to present medical malpractice claims and similar liabilities without consideration of insurance recoveries. Related insurance recoveries are to be presented as a receivable net of a valuation allowance for uncollectible amounts. The accompanying financial statements present reserves for known malpractice claims. As of December 31, 2012 and 2011, the company had no receivables for related insurance recoveries. Had any such receivables existed, they would be presented on an undiscounted basis based upon loss projections.

NOTE_2_SUMMARY_OF_SIGNIFICANT_3

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
Basis of Presentation	BASIS OF PRESENTATION
	The unaudited interim financial statements have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
	The financial information furnished herein reflects all adjustments, consisting of normal recurring items that, in the opinion of management, are necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the interim periods.  The results of operations for the six months ended June 30, 2013 are not necessarily indicative of the results to be expected for the year ending December 31, 2013.
	The information included in these interim unaudited condensed financial statements should be read in conjunction with the Company’s Registration Statement on Form S-1 for the year ended December 31, 2012.
Use of Estimates	Use of Estimates
	The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The areas involving the most significant use of estimates include the estimated realizable value of accounts receivable, contractual adjustment of gross billings, medical malpractice insurance receivable and payables for known claims and liabilities for claims incurred but not reported (IBNR) related to medical malpractice. These estimates are based on knowledge of current events and anticipated future events. The Company adjusts these estimates each period as more current information becomes available. The impact of any changes in estimates is included in the determination of earnings in the period in which the estimate is adjusted. Actual results may ultimately differ materially from those estimates.
Cash	Cash
	The Company considers cash in banks and other highly liquid investments with insignificant interest rate risk and maturities of three months or less at the time of acquisition to be cash and cash equivalents. At June 30, 2013 and December 31, 2012, the Company had no cash equivalents. The Company maintains cash accounts in financial institutions that are guaranteed by the Federal Deposit Insurance Corporation (“FDIC”). FDIC insurance has increased from $100,000 to $250,000 per depositor as of December 31, 2012. Deposits in excess of FDIC insurance totaled approximately $159,000 and $637,000 at June 30, 2013 and December 31, 2012, respectively.
Accounts Receivable	Accounts Receivable
	Accounts receivable represent amounts due from third-party payors, including government sponsored Medicare and Medicaid programs, insurance companies and patients for medical services provided. Accounts receivable are recorded and stated at the amount expected to be collected and have been adjusted to reflect the differences between charges and the estimated reimbursable amounts.
	Accounts receivable balances as of June 30, 2013 and December 31, 2012 were as follows:
			2013			2012
	Accounts Receivable	$	—		$	1,074,528
	Less Contractual Allowances and Allowances for Doubtful Accounts		—			(937,057	)
		$	—		$	137,471
Property and Equipment	Property and Equipment
	Property and equipment are recorded at cost and depreciated on a straight-line basis over the estimated useful life of the asset. Expenditures for major renewals and betterments that extend the useful lives of properly and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets
	The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recovered.
	The Company assesses the recoverability of its long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives, against their respective carrying amounts.  Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.  The Company determined that there were no impairments of long-lived assets as of June 30, 2013 and December 31, 2012.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	U.S. GAAP for fair value measurements establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three levels. The fair value hierarchy gives the highest priority to quoted market prices (unadjusted) in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). Level 2 inputs are inputs, other than quoted prices included within Level 1, which are observable for the asset or liability, either directly or indirectly. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, deposits, accounts payable and accrued liabilities, approximate their fair values because of the short maturity of these instruments.
Revenue Recognition	Revenue Recognition
	Hospitalist/Intensivist - Revenue consists primarily of net patient service revenues that are recorded based upon established billing rates less allowances for contractual adjustments. Revenues are recorded during the period the healthcare services are provided, based upon the estimated amounts due from the patients and third party payors, including federal and state agencies (under the Medicare and Medicaid programs), managed care health plans and commercial insurance companies. Estimates of contractual allowances under third-party payor arrangements are based upon the payment terms specified in the related contractual agreements. Third-party payor contractual payment terms are generally based upon predetermined rates per diagnosis, per diem rates, or discounted fee-for-service rates.
	The Company derives a significant portions of its revenues from third party insurers and accordingly receives discounts from standard charges. The Company must estimate the total amount of these discounts to prepare its financial statements. The various managed care contracts under which these discounts must be calculated are complex and are subject to interpretation and adjustment. These interpretations sometimes result in payments that differ from the Company’s estimates. Additionally, updated regulations and contract renegotiations occur frequently, necessitating regular review and assessment of the estimation process by management. Changes in estimates related to the allowance for contractual discounts affect revenues reported in the Company’s statement of operations in the period of the change.
	The Medicare and Medicaid reimbursing entities (“Entities”) provide a substantial portion of the Company revenues. These Entities are subject to numerous laws and regulations of federal, state and local governments, including but not limited to matters such as licensure, accreditation, participation requirements, reimbursement formulas and fraud and abuse. Compliance with standards and other regulations can be subject to future government review and interpretation. Any future changes in federal and state reimbursement funding mechanisms could affect the Company.
	Interior Design - The Company follows ASC 605-10-S99-1 of the FASB Accounting Standards Codification for revenue recognition. The Company will recognize revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when it has persuasive evidence of an arrangement that the services have been rendered to the customer, the sales price is fixed or determinable, and collectability is reasonably assured.
Income Taxes	Income Taxes
	The Company follows Section 740-10-30 of the FASB Accounting Standards Codification, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the Statements of Operations in the period that includes the enactment date.
	The Company adopted section 740-10-25 of the FASB Accounting Standards Codification (“Section 740-10-25”). Section 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements.  Under Section 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of Section 740-10-25.
Earnings Per Share	Earnings Per Share
	The Company computes earnings per share in accordance with the provisions of FASB ASC Topic 260, "Earnings Per Share," which specifies the computation, presentation and disclosure requirements for earnings (loss) per share for entities with publicly held common stock.  Basic earnings per share are computed by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding during the period.  Diluted earnings per share are computed assuming the exercise of dilutive stock options under the treasury stock method and the related income tax effects.
	As of June 30, 2013 and 2012, we had 250,000 shares of Convertible Preferred Stock outstanding convertible into 2,500,000 common shares.
	The following tables set forth the computation of basic and diluted earnings per share as shown on the face of the accompanying Statements of Operations:
		For the Six Months Ended June 30,
		2013									2012
		Net Loss			Shares			Per Share Amount			Net Income		Shares		Per Share Amount
	Basic Earnings per Share:	$	(527,780	)							$	3,617,993
	Net income (loss)
	Amount allocated to participating securities		—									—
	Net income (loss) available for basic common shares and basic earnings per share	$	(527,780	)		48,612,365		$	(0.01	)	$	3,617,993		44,560,167	$	0.08
	Diluted Earnings per Share:
	Net income (loss)	$	(527,780	)							$	3,617,993
	Amount allocated to participating securities		—
	Adjustment for dilutive potential common shares		—			—						—		2,500,000
	Net income (loss) available for diluted common shares and diluted earnings per share	$	(527,780	)		48,612,365		$	(0.01	)	$	3,617,993		47,060,167	$	0.08
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	There have been no accounting pronouncements or changes in accounting pronouncements during the six months ended June 30, 2013 that are expected to have a material impact on the Company’s financial position, results of operations or cash flows.  Accounting pronouncements that became effective during the six months ended June 30, 2013 did not have a material impact on disclosures or on the Company’s financial position, results of operations or cash flows.

NOTE_2_SUMMARY_OF_SIGNIFICANT_4

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) (Annual Report) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
Accounts Receivable Balances			2012			2011
	Accounts Receivable		1,074,528		$	3,163,267
	Less Contractual Allowances and Allowances for Doubtful Accounts		(937,057	)		(1,976,713	)
			137,471		$	1,186,554
Earnings Per Share, Basic and Diluted		Years Ended December 31,
		2012								2011
		Net Income			Shares			Per Share Amount		Net Loss			Shares		Per Share Amount
	Basic Earnings per Share:	$	2,658,917							$	(577,685	)
	Net income (loss)
	Amount allocated to participating securities		(210,000	)							—
	Net income available for basic common shares and basic earnings per share	$	2,448,917			46,597,338		$	0.05	$	(577,685	)		43,612,365	$	(0.01	)
	Diluted Earnings per Share:
	Net income (loss)	$	2,658,617							$	(577,685	)
	Amount allocated to participating securities		(210,000	)
	Adjustment for dilutive potential common shares					2,500,000					—			—
	Net income available for diluted common shares and diluted earnings per share	$	2,448,917			49,097,338		$	0.05	$	(577,685	)		43,612,365	$	(0.01	)

NOTE_2_SUMMARY_OF_SIGNIFICANT_5

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
Accounts Receivable Balances			2013			2012
	Accounts Receivable	$	—		$	1,074,528
	Less Contractual Allowances and Allowances for Doubtful Accounts		—			(937,057	)
		$	—		$	137,471
Basic and Diluted Earnings Per Share		For the Six Months Ended June 30,
		2013									2012
		Net Loss			Shares			Per Share Amount			Net Income			Shares		Per Share Amount
	Basic Earnings per Share:	$	(527,780	)							$	3,617,993
	Net income (loss)
	Amount allocated to participating securities		—									—
	Net income (loss) available for basic common shares and basic earnings per share	$	(527,780	)		48,612,365		$	(0.01	)	$	3,617,993			44,560,167	$	0.08
	Diluted Earnings per Share:
	Net income (loss)	$	(527,780	)							$	3,617,993
	Amount allocated to participating securities		—
	Adjustment for dilutive potential common shares		—			—						—			2,500,000
	Net income (loss) available for diluted common shares and diluted earnings per share	$	(527,780	)		48,612,365		$	(0.01	)	$	3,617,993			47,060,167	$	0.08
	Integrated Inpatient Solutions, Inc.
	Condensed Financial Statements
	30-Jun-13
	(Unaudited)
	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
		For the Three Months Ended June 30,
		2013									2012
		Net Loss			Shares			Per Share Amount			Net Loss			Shares		Per Share Amount
	Basic Earnings per Share:	$	(257,166	)							$	(791,712	)
	Net income (loss)
	Amount allocated to participating securities		—									—
	Net income (loss) available for basic common shares and basic earnings per share	$	(257,166	)		48,612,365		$	(0.01	)	$	(791,712	)		45,507,969	$	(0.02	)
	Diluted Earnings per Share:
	Net income (loss)	$	(257,166	)							$	(791,712	)
	Amount allocated to participating securities
	Adjustment for dilutive potential common shares		—			—						—			—
	Net income (loss) available for diluted common shares and diluted earnings per share	$	(257,166	)		48,612,365		$	(0.01	)	$	(791,712	)		45,507,969	$	(0.02	)

NOTE_4_PREPAID_EXPENSES_AND_OT2

NOTE 4 - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) (Annual Report) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
Prepaid Expenses and Other Current Assets			2012		2011
	Escrow deposit held for indemnification	$	300,000	$	—
	Prepaid insurance-medical professional liability		121,197		26,741
	Other current assets		—		40,560
		$	421,197	$	67,301

NOTE_4_PREPAID_EXPENSES_AND_OT3

NOTE 4 - PREPAID EXPENSES AND OTHER CURRENT ASSETS (Tables) (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
Prepaid Expenses and Other Current Assets			2013		2012
	Escrow Deposit held for indemnification	$	300,000	$	300,000
	Prepaid insurance - medical professional liability		183,242		121,197
		$	483,242	$	421,197

NOTE_5_PROPERTY_AND_EQUIPMENT_1

NOTE 5 - PROPERTY AND EQUIPMENT (Tables) (Annual Report) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
Property and Equipment		2012			2011			Estimated Useful Life
	Computer and Office Equipment	$	33,868		$	33,868		5 -7 years
	Furniture and Fixtures		18,530			18,530		7 years
			52,398			52,398
	Less: Accumulated Depreciation		(40,574	)		(37,777	)
		$	11,824		$	14,621

NOTE_5_PROPERTY_AND_EQUIPMENT_2

NOTE 5 - PROPERTY AND EQUIPMENT (Tables) (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
Property and Equipment		2012			2011			Estimated Useful Life
	Computer and Office Equipment	$	33,868		$	33,868		5 -7 years
	Furniture and Fixtures		18,530			18,530		7 years
			52,398			52,398
	Less: Accumulated Depreciation		(46,445	)		(40,574	)
		$	5,953		$	11,824

NOTE_6_DEBT_Tables

NOTE 6 - DEBT (Tables) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
Debt Obligations			2012		2011
	Note payable to Citibank payable $993 monthly. Interest accrues at a variable rate based upon a rate of prime plus 1%. The loan is secured by all property and assets of the Company and is personally guaranteed by certain members of management.	$	—	$	8,667
	Citibank, line of credit, payable over 60 months accruing interest at 4.25% per year. The original principal balance was $500,000. The loan is payable November, 25, 2012.		—		485,527
	Less current portion		—		(494,194	)
		$	—	$	—
	Long-term debt

NOTE_7_INCOME_TAXES_Tables

NOTE 7 - INCOME TAXES (Tables) (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
Components of the Company's Net Current and Deferred Income Tax Provision					Six Months Ended June 30, 2013								Six Months Ended June 30, 2012
					Total				Continuing Operations		Discontinued Operations		Total		Continuing Operations		Discontinued Operations
		Current:				—				—		—		2,000,009		—		2,000,009
		Total				—				—		—		2,000,009		—		2,000,009
Effective Income Tax Rate Reconciliation			2013				2012
	Statutory rate			34	%			30	%
	State income taxes, net of Federal tax benefit			5.5				5.5
				39.5				35.5
	Less: Valuation Allowance			(39.50	)			—
				0	%			35.5	%

NOTE_8_INCOME_TAXES_Tables

NOTE 8 - INCOME TAXES (Tables) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
Components of the Company's Net Current and Deferred Income Tax Provision					Fiscal year ended December 31, 2012									Fiscal year ended December 31, 2011
					Total				Continuing Operations			Discontinued Operations		Total		Continuing Operations		Discontinued Operations
		Current:			$	1,610,509			$	(31,579	)	$	1,414,181	$	—	$		$
		Deferred:			$	—			$			$		$	12,600	$		$	12,600
		Total			$	1,610,509			$	(31,579	)	$	1,414,181	$	12,600	$	—	$	12,600
Deferred Tax Assets			2012				2011
	Deferred tax assets:
	Net operating loss		$	—			$	12,600
	Net deferred tax asset		$	—			$	12,600
Effective Income Tax Rate Reconciliation			2012				2011
	Statutory rate			34	%			34	%
	State income taxes, net of Federal tax benefit			5.5				5.5
	Permanent differences			—				(35.30	)
	Valuation allowance-deferred tax asset from NOL			—				(2.10	)
	Effective rate			39.5	%			(2.10	)%

NOTE_11_Discontinued_Operation1

NOTE 11 - Discontinued Operations (Tables) (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
Discontinued Operations		Six Months Ended June 30,
		2013			2012
	Patient Service Revenue (net of contractual allowances and discounts)	$	109,463		$	4,294,812
	Operating expenses:
	Cost of services-physicians		225,964			2,054,757
	General and administrative		211,530			3,033,497
	Total operating expenses		437,494			5,088,254
	Other income (expenses)
	Interest expense, net		—			(6,794	)
	Gain on sale of assets		—			6,500,000
	Total other income (expenses)		—			6,493,206
	Income (loss) on discontinued operations	$	(328,031	)	$	5,699,764

NOTE_12_DISCONTINUED_OPERATION1

NOTE 12 - DISCONTINUED OPERATIONS (Tables) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
Discontinued Operations in the Statement of Operations		2012			2011
	Patient Service Revenue (net of contractual allowances and discounts)	$	2,785,498		$	6,777,591
	Operating expenses:
	Cost of services-physicians		3,234,533			5,731,549
	General and administrative		1,705,449			1,451,496
	Professional liability settlement		—			100,000
	Total operating expenses		4,939,982			7,283,045
	Other income (expense)
	Interest expense, net		(6,792	)		(23,878	)
	Gain on sale of assets		6,500,000			—
	Total other income (expenses)		6,493,208			(23,878	)
	Income (loss) from discontinued operation	$	4,338,724		$	(529,332	)

NOTE_2_SUMMARY_OF_SIGNIFICANT_6

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable Balances (Details) (Annual Report) (Annual Report [Member], USD $)	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Accounts Receivable	$1,074,528	$3,163,267
Less Contractual Allowances and Allowances for Doubtful Accounts	-937,057	-1,976,713
Accounts Receivable, Net	$137,471	$1,186,554

NOTE_2_SUMMARY_OF_SIGNIFICANT_7

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Accounts Receivable Balances (Details) (Quarterly Report [Member], USD $)	Jun. 30, 2013	Dec. 31, 2012
Quarterly Report [Member]
Accounts Receivable		$1,074,528
Less Contractual Allowances and Allowances for Doubtful Accounts		-937,057
Accounts Receivable, Net		$137,471

NOTE_2_SUMMARY_OF_SIGNIFICANT_8

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share, Basic and Diluted (Details) (Annual Report) (Annual Report [Member], USD $)	1 Months Ended	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Basic Earnings per Share:
Net income (loss)		$2,658,917
Amount allocated to participating securities
Net income available for basic common shares and basic earnings	2,448,917		-577,685
Net income available for basic common shares and basic earnings, Shares	46,597,338		43,612,365
Net income available for basic common shares and basic earnings, Per Share	$0.05	$0.05	($0.01)
Diluted Earnings per Share:
Net income (loss)	2,658,917
Amount allocated to participating securities	-210,000
Adjustment for dilutive potential common shares, Shares	2,500,000
Net income available for diluted common shares and diluted earnings	$2,448,917		($577,685)
Net income available for diluted common shares and diluted earnings, Shares	49,097,338		43,612,365
Net income available for diluted common shares and diluted earnings, Per Share	$0.05	$0.05	($0.01)

NOTE_2_SUMMARY_OF_SIGNIFICANT_9

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic and Diluted Earnings Per Share (Details) (Quarterly Report [Member], USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Quarterly Report [Member]
Basic Earnings per Share:
Net income (loss)	($257,166)	($791,712)	($527,780)	($3,617,993)
Amount allocated to participating securities
Net income available for basic common shares and basic earnings	-257,166	-791,712	-527,780	3,617,993
Net income available for basic common shares and basic earnings, Shares	48,612,365	45,507,969	48,612,365	44,560,167
Net income available for basic common shares and basic earnings, Per Share	($0.01)	($0.02)	($0.01)	$0.08
Diluted Earnings per Share:
Net income (loss)	-257,166	-791,712	-527,780	3,617,993
Amount allocated to participating securities
Adjustment for dilutive potential common shares, Shares				2,500,000
Net income available for diluted common shares and diluted earnings	($257,166)	($791,712)	($527,780)	$3,617,993
Net income available for diluted common shares and diluted earnings, Shares	48,612,365	45,507,969	48,612,365	47,060,167
Net income available for diluted common shares and diluted earnings, Per Share	($0.01)	($0.02)	($0.01)	$0.08

Recovered_Sheet1

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (Annual Report) (Annual Report [Member], USD $)	Dec. 31, 2012	31-May-12	Dec. 31, 2011
Annual Report [Member]
FDIC Insured Amount	$250,000
Cash, Uninsured Amount	$637,000		$0
Convertible Preferred Stock Outstanding	250,000		750,000
Convertible Preferred Stock, Shares Issued Upon Conversion	2,500,000	5,000,000	7,500,000

Recovered_Sheet2

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (Quarterly Report [Member], USD $)	Jun. 30, 2013	Dec. 31, 2012	31-May-12
Quarterly Report [Member]
FDIC Insured Amount	$250,000
Cash, Uninsured Amount	$159,000	$637,000
Convertible Preferred, Shares Outstanding	250,000
Shares Issued Upon Conversion	2,500,000		5,000,000

NOTE_3_ASSET_SALE_Details_Narr

NOTE 3 - ASSET SALE (Details Narrative) (Annual Report) (Annual Report [Member], USD $)	12 Months Ended
	Dec. 31, 2012
Annual Report [Member]
Sale of Intangible Assets	$6,500,000
Asset held for sale, Carrying Value	0
Gain on Sale of Asset	6,500,000
Escrow Deposit	$300,000

NOTE_3_ASSET_SALE_Details_Narr1

NOTE 3 - ASSET SALE (Details Narrative) (Quarterly Report [Member], USD $)	6 Months Ended
	Jun. 30, 2013
Quarterly Report [Member]
Sale of Intangible Assets	$6,500,000
Asset held for sale, Carrying Value	0
Gain on Sale of Asset	6,500,000
Escrow Deposit	$300,000

NOTE_4_PREPAID_EXPENSES_AND_OT4

NOTE 4 - PREPAID EXPENSES AND OTHER CURRENT ASSETS - Prepaid Expenses and Other Current Assets (Details) (Annual Report) (Annual Report [Member], USD $)	Dec. 31, 2012	Dec. 31, 2011
Escrow deposit held for indemnification	$300,000
Other current assets		40,560
Total Prepaid Expenses and Other Current Assets	421,197	67,301
Professional Malpractice Liability Insurance [Member]
Prepaid insurance-medical professional liability	$121,197	$26,741

NOTE_4_PREPAID_EXPENSES_AND_OT5

NOTE 4 -PREPAID EXPENSES AND OTHER CURRENT ASSETS - Prepaid Expenses and Other Current Assets (Details) (Quarterly Report [Member], USD $)	Jun. 30, 2013	Dec. 31, 2012
Quarterly Report [Member]
Escrow deposit held for indemnification	$300,000	$300,000
Prepaid insurance-medical professional liability	183,242	121,197
Total Prepaid Expenses and Other Current Assets	$483,242	$421,197

NOTE_5_PROPERTY_AND_EQUIPMENT_3

NOTE 5 - PROPERTY AND EQUIPMENT - Property and Equipment (Details) (Annual Report) (Annual Report [Member], USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Property and Equipment Gross	$52,398	$52,398
Less: Accumulated Depreciation	-40,574	-37,777
Property and Equipment Net	11,824	14,621
Computer and Office Equipment
Property and Equipment Gross	33,868	33,868
Estimated Useful Life	7 years
Furniture and Fixtures
Property and Equipment Gross	$18,530	$18,530
Estimated Useful Life	7 years

NOTE_5_PROPERTY_AND_EQUIPMENT_4

NOTE 5 - PROPERTY AND EQUIPMENT - Property and Equipment (Details) (Quarterly Report [Member], USD $)	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2013	Dec. 31, 2012	Dec. 31, 2012	Jun. 30, 2013
			Computer and Office Equipment	Computer and Office Equipment	Furniture and Fixtures	Furniture and Fixtures
Property and Equipment Gross	$52,398	$52,398	$33,868	$33,868	$18,530	$18,530
Less: Accumulated Depreciation	-46,445	-40,574
Property and Equipment Net	$5,953	$11,824
Estimated Useful Life			7 years		7 years

NOTE_5_PROPERTY_AND_EQUIPMENT_5

NOTE 5 - PROPERTY AND EQUIPMENT (Details Narrative) (Annual Report) (Annual Report [Member], USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Depreciation Expense	$2,797	$5,997

NOTE_5_PROPERTY_AND_EQUIPMENT_6

NOTE 5 - PROPERTY AND EQUIPMENT (Details Narrative) (Quarterly Report [Member], USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Quarterly Report [Member]
Depreciation Expense	$5,871	$1,399

NOTE_6_DEBT_Debt_Obligations_D

NOTE 6 - DEBT - Debt Obligations (Details) (Annual Report [Member], USD $)	Dec. 31, 2012	Dec. 31, 2011
Long Term Debt
Less Current Portion		-494,194
Citibank Note Payable
Long Term Debt		8,667
Citibank Line of Credit
Long Term Debt		$485,527

NOTE_6_DEBT_Details_Narrative

NOTE 6 - DEBT (Details Narrative) (Annual Report [Member], USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Interest Expense	$6,797	$23,889
Repayment of Debt	$494,194

NOTE_6_OTHER_ASSETS_Details_Na

NOTE 6 - OTHER ASSETS (Details Narrative) (Quarterly Report [Member], USD $)	Jun. 30, 2013
Quarterly Report [Member]
Assets, Current	$183,242
Other Assets, Current	$184,961

NOTE_7_INCOME_TAXES_Components

NOTE 7 - INCOME TAXES - Components of the Company's Net Current and Deferred Income Tax Provision (Details) (Quarterly Report [Member], USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Current:		$2,000,009
Total		2,000,009
Discontinued Operations [Member]
Current:		2,000,009
Total		2,000,009
Continuing Operations [Member]
Current:
Total

NOTE_7_INCOME_TAXES_Effective_

NOTE 7 - INCOME TAXES - Effective Income Tax Rate Reconciliation (Details) (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Quarterly Report [Member]
Statutory rate	34.00%	30.00%
State income taxes, net of Federal tax benefit	5.50%	5.50%
Permanent differences	39.50%	3550.00%
Valuation allowance-deferred tax asset from NOL	-39.50%
Effective rate	0.00%	35.50%

NOTE_7_RELATED_PARTY_TRANSACTI1

NOTE 7 - RELATED PARTY TRANSACTIONS (Details Narrative) (Annual Report [Member], USD $)	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Accounts Payable, Related Parties	$7,000	$53,000
Employee Related Liabilities - Related Parties	$7,000	$138,000

NOTE_7_INCOME_TAXES_Details_Na

NOTE 7 - INCOME TAXES (Details Narrative) (Quarterly Report [Member], USD $)	Jun. 30, 2013	Dec. 31, 2012
Quarterly Report [Member]
Refundable Income Taxes	$69,585	$69,585

NOTE_8_INCOME_TAXES_Components

NOTE 8 - INCOME TAXES - Components of the Company's Net Current and Deferred Income Tax Provision (Details) (Annual Report [Member], USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Current:	$1,610,509	($31,579)
Deferred:
Total	1,610,509	-31,579
Continuing Operations [Member]
Current:	1,414,181
Deferred:		12,600
Total	1,414,181	12,600
Discontinued Operations [Member]
Current:
Deferred:		12,600
Total		$12,600

NOTE_8_INCOME_TAXES_Deferred_T

NOTE 8 - INCOME TAXES - Deferred Tax Assets (Details) (Annual Report [Member], USD $)	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Deferred tax assets:
Net operating loss		$12,600
Net deferred tax asset		$12,600

NOTE_8_INCOME_TAXES_Effective_

NOTE 8 - INCOME TAXES - Effective Income Tax Rate Reconciliation (Details) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Statutory rate	34.00%	34.00%
State income taxes, net of Federal tax benefit	5.50%	5.50%
Permanent differences		-35.30%
Valuation allowance-deferred tax asset from NOL		-2.10%
Effective rate	39.50%	-2.10%

NOTE_8_INCOME_TAXES_Details_Na

NOTE 8 - INCOME TAXES (Details Narrative) (Annual Report [Member], USD $)	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Operating Loss Carryforwards	$0	$32,000
Refundable Income Taxes	$69,585	$22,347

NOTE_8_STOCKHOLDERS_EQUITY_Det

NOTE 8 - STOCKHOLDERS' EQUITY (Details Narrative) (Quarterly Report [Member], USD $)	1 Months Ended	6 Months Ended
	31-May-12	Jun. 30, 2013	Dec. 31, 2012	Feb. 14, 2012	Feb. 13, 2012
Quarterly Report [Member]
Preferred Stock, Shares Authorized		10,000,000
Preferred Stock, Par or Stated Value Per Share		$0.00	$0.00
Convertible Preferred Stock, Shares Issued Upon Conversion	5,000,000	2,500,000
Conversion of Stock, Shares Converted	500,000
Preferred Stock, Shares Outstanding	750,000	250,000	250,000
Common Stock, Par Value		$0.00	$0.00	$0.00
Common Stock, Shares Authorized		100,000,000	100,000,000	100,000,000	50,000,000
Shares Issued Upon Conversion		10

NOTE_9_STOCKHOLDERS_EQUITY_Det

NOTE 9 - STOCKHOLDERS' EQUITY (Details Narrative) (Annual Report [Member], USD $)	1 Months Ended	2 Months Ended	12 Months Ended
	31-May-12	Apr. 30, 2012	Dec. 31, 2012	Feb. 14, 2012	Feb. 13, 2012	Dec. 31, 2011
Annual Report [Member]
Preferred Stock, Shares Authorized			10,000,000
Preferred Stock, Par or Stated Value Per Share			$0.00			$0.00
Convertible Preferred Stock, Shares Issued Upon Conversion	5,000,000		2,500,000			7,500,000
Conversion of Stock, Shares Converted	500,000
Preferred Stock, Shares Outstanding	750,000		250,000			750,000
Common Stock, Par Value			$0.00	$0.00		$0.00
Common Stock, Shares Authorized			100,000,000	100,000,000	50,000,000	100,000,000
Dividends		$1,431,146	($1,431,147)
Shares Issued Upon Conversion			10

NOTE_9_COMMITMENTS_AND_CONTING1

NOTE 9 - COMMITMENTS AND CONTINGENCIES (Details Narrative) (Quarterly Report [Member], USD $)	1 Months Ended				6 Months Ended
	Apr. 30, 2013	Nov. 30, 2011	Oct. 31, 2011	Jul. 31, 2007	Jun. 30, 2013	Jun. 30, 2012
Quarterly Report [Member]
Lease Expense	$450			$3,000	$7,866	$12,941
Litigation Settlement Expense		100,000	30,000
Payments for Legal Settlements			30,000			-38,486
Litigation Settlement Amount					$79,000

NOTE_10_COMMITMENTS_AND_CONTIN1

NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details Narrative) (Annual Report [Member], USD $)	1 Months Ended			12 Months Ended
	Nov. 30, 2011	Oct. 31, 2011	Jul. 31, 2007	Dec. 31, 2012	Dec. 31, 2011
Annual Report [Member]
Lease Expense			$3,000	$23,150	$34,301
Litigation Settlement Expense	100,000	30,000
Payments for Legal Settlements		30,000		-38,486	117,865
Litigation Settlement Amount	$79,000

NOTE_10_CONCENTRATIONS_Details

NOTE 10 - CONCENTRATIONS (Details Narrative) (Quarterly Report [Member])	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Affiliated Entity [Member]
Concentration Risk Percentage	4.00%	2.00%
custom:UnAffiliatedEntityMember
Concentration Risk Percentage	96.00%	35.00%

NOTE_11_Discontinued_Operation2

NOTE 11 - Discontinued Operations - Discontinued Operations (Details) (Quarterly Report [Member], USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Operating expenses:
Cost of services-physicians			$5,741
General and administrative	111,787	49,579	196,170	81,762
Total operating expenses	111,787	49,579	196,170	81,762
Other income (expense)
Gain on sale of assets				-6,500,000
Income (loss) from discontinued operation	-147,541	-742,133	-328,031	-3,699,755
Discontinued Operations [Member]
Patient Service Revenue (net of contractual allowances and discounts)			109,463	4,294,812
Operating expenses:
Cost of services-physicians			225,964	2,054,757
General and administrative			211,530	3,033,497
Total operating expenses			437,494	5,088,254
Other income (expense)
Interest expense, net				-6,794
Gain on sale of assets				6,500,000
Total other income (expenses)				6,493,206
Income (loss) from discontinued operation			($328,031)	$5,699,764

NOTE_11_CONCENTRATIONS_Details

NOTE 11 - CONCENTRATIONS (Details Narrative) (Annual Report [Member])	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Affiliated Entity [Member]
Concentration Risk Percentage	1.00%	6.00%
custom:UnAffiliatedEntityMember
Concentration Risk Percentage	94.00%	33.00%

Recovered_Sheet3

NOTE 12 - Discontinued Operations - Discontinued Operations in the Statement of Operations (Details) (Annual Report [Member], USD $)	1 Months Ended		12 Months Ended
	Nov. 30, 2011	Oct. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Operating expenses:
General and administrative			$100,877	$60,953
Professional liability settlement	100,000	30,000
Other income (expense)
Gain on sale of assets			-6,500,000
Income (loss) from discontinued operation			2,728,215	-516,732
Discontinued Operations [Member]
Patient Service Revenue (net of contractual allowances and discounts)			2,785,498	6,777,591
Operating expenses:
Cost of services-physicians			3,234,533	5,731,549
General and administrative			1,705,449	1,451,496
Professional liability settlement				100,000
Total operating expenses			4,939,982	7,283,045
Other income (expense)
Interest expense, net			-6,792	-23,878
Gain on sale of assets			6,500,000
Total other income (expenses)			6,493,208	-23,878
Income (loss) from discontinued operation			$4,338,724	($529,332)